Medicamen Organics Limited (NSE:MEDIORG)
India · Delayed Price · Currency is INR 21.50
+1.00 (4.88%)
Jun 17, 2026, 11:38 AM IST
Medicamen Organics Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 226.3 | 381.88 | 252.72 | 221.47 | 209.75 | |
Revenue Growth (YoY) | -40.74% | 51.11% | 14.11% | 5.59% | -16.26% |
Cost of Revenue | 185.98 | 247.85 | 157.99 | 157.97 | 156.6 |
Gross Profit | 40.32 | 134.03 | 94.73 | 63.5 | 53.16 |
Selling, General & Admin | 37.17 | 38.71 | 34.27 | 32.63 | 29.18 |
Other Operating Expenses | 40.66 | 29.62 | 13.09 | 12.04 | 11.99 |
Operating Expenses | 86.8 | 75.69 | 54.55 | 51.79 | 47.98 |
Operating Income | -46.48 | 58.33 | 40.18 | 11.71 | 5.18 |
Interest Expense | -7.09 | -4.8 | -6.24 | -5.66 | -4.36 |
Interest & Investment Income | - | 0.95 | 0.13 | 0.08 | 0.23 |
Currency Exchange Gain (Loss) | - | 0.16 | 0.02 | -0.14 | -0.01 |
Other Non Operating Income (Expenses) | 0.79 | -0.34 | -0.24 | -0.47 | -0.38 |
EBT Excluding Unusual Items | -52.78 | 54.3 | 33.86 | 5.53 | 0.67 |
Other Unusual Items | - | 0 | 10.51 | 8.07 | 1.88 |
Pretax Income | -52.78 | 54.3 | 44.37 | 13.6 | 2.55 |
Income Tax Expense | -12.59 | 13.83 | 18.13 | 3.9 | 1.54 |
Net Income | -40.19 | 40.47 | 26.24 | 9.69 | 1.01 |
Net Income to Common | -40.19 | 40.47 | 26.24 | 9.69 | 1.01 |
Net Income Growth | - | 54.22% | 170.74% | 855.92% | -58.46% |
Shares Outstanding (Basic) | 12 | 11 | 8 | 6 | 6 |
Shares Outstanding (Diluted) | 12 | 11 | 8 | 6 | 6 |
Shares Change (YoY) | 6.61% | 46.18% | 26.05% | - | - |
EPS (Basic) | -3.41 | 3.67 | 3.47 | 1.62 | 0.17 |
EPS (Diluted) | -3.41 | 3.66 | 3.47 | 1.62 | 0.17 |
EPS Growth | - | 5.48% | 114.79% | 855.92% | -58.46% |
Free Cash Flow | -63.34 | -69.9 | -40.13 | -8.73 | -5.79 |
Free Cash Flow Per Share | -5.37 | -6.32 | -5.31 | -1.46 | -0.96 |
Gross Margin | 17.82% | 35.10% | 37.48% | 28.67% | 25.34% |
Operating Margin | -20.54% | 15.28% | 15.90% | 5.29% | 2.47% |
Profit Margin | -17.76% | 10.60% | 10.38% | 4.38% | 0.48% |
Free Cash Flow Margin | -27.99% | -18.30% | -15.88% | -3.94% | -2.76% |
EBITDA | -40.28 | 64.31 | 47.38 | 18.83 | 11.98 |
EBITDA Margin | -17.80% | 16.84% | 18.75% | 8.50% | 5.71% |
D&A For EBITDA | 6.2 | 5.97 | 7.19 | 7.12 | 6.8 |
EBIT | -46.48 | 58.33 | 40.18 | 11.71 | 5.18 |
EBIT Margin | -20.54% | 15.28% | 15.90% | 5.29% | 2.47% |
Effective Tax Rate | - | 25.47% | 40.85% | 28.71% | 60.27% |
Revenue as Reported | 227.09 | 382.83 | 252.9 | 229.62 | 211.87 |
Advertising Expenses | - | 1.58 | 0.3 | 0.56 | 0.11 |